Alfuzosin hydrochloride
- Product NDC
- 76282-302
- 11-digit product format
- 762820302
- Labeler code
- 76282
- Product ID
- 76282-302_663c0846-dc2c-409f-9fe0-bf2901ff92da
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alfuzosin hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Exelan Pharmaceuticals Inc.
- Application
- ANDA090284
- Marketing category
- ANDA
- Marketing start
- 2012-10-02
- Substance
- ALFUZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090284-001 | ALFUZOSIN HYDROCHLORIDE | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090284-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A090284-001 | ALFUZOSIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-01-17 | cb3db0bc1861… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A090284-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090284-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A090284-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090284-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090284-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090284-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090284-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090284-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090284-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A090284-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090284-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090284-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090284-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A090284-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090284-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A090284-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A090284-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A090284-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A090284-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A090284-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090284-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A090284-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A090284-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A090284-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A090284-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A090284-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A090284-001 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090284-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A090284-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A090284-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A090284-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A090284-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A090284-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A090284-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A090284-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A090284-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A090284-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A090284-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A090284-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A090284-001 | AB | 1 | cb3db0bc1861… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Alfuzosin hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ALFUZOSIN HYDROCHLORIDE | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 75046A1XTN | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 861132 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f075a897-7bef-4799-b7e2-7e051c461443 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 8b671e1a-6f8a-5de4-69a7-83132df7952d | Product name | 3 | 20201015 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76282-302-01 | Alfuzosin hydrochloride | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 11 | |
| 76282-302-05 | Alfuzosin hydrochloride | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | 11 | |
| 76282-302-10 | Alfuzosin hydrochloride | 1000 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 1000 | 11 | |
| 76282-302-12 | Alfuzosin hydrochloride | 120 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 120 | 11 | |
| 76282-302-90 | Alfuzosin hydrochloride | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 11 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76282-302-01 | EA - Each | 76282-302 | adb2582e-2546-4a3e-85b0-b639f174b52d | 1 | 2013-02-13 |
| 76282-302-05 | EA - Each | 76282-302 | 35f5e404-f900-4ccd-82eb-846b095cc80e | 1 | 2014-05-02 |
| 76282-302-10 | EA - Each | 76282-302 | aa84c026-2961-435c-af6c-292205a0b24c | 1 | 2024-07-12 |
| 76282-302-12 | EA - Each | 76282-302 | a263f4e1-df21-4a73-bf23-5512d8ccb1c4 | 1 | 2023-04-07 |
| 76282-302-90 | EA - Each | 76282-302 | ae9b4a7f-2960-4d72-b371-90aff5e16023 | 1 | 2019-04-11 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alfuzosin hydrochloride | ALFUZOSIN HYDROCHLORIDE | Exelan Pharmaceuticals Inc. | f075a897-7bef-4799-b7e2-7e051c461443 | 2023-10-01 | Warnings, Adverse reactions | 090284 ANDA090284 76282-302 |
| Alfuzosin Hydrochloride extended release | ALFUZOSIN HYDROCHLORIDE | Cipla USA Inc. | 3cc028d5-309f-4ce3-a2d7-5804ab57677d | 2020-10-01 | Warnings, Adverse reactions | 090284 ANDA090284 |
| Alfuzosin hydrochloride | ALFUZOSIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 790fe381-4a83-402e-b6c0-2ecde9cac7a7 | 2017-12-19 | Warnings, Adverse reactions | 090284 ANDA090284 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 861132 | alfuzosin HCl 10 MG 24HR Extended Release Oral Tablet | PSN | f075a897-7bef-4799-b7e2-7e051c461443 | 11 |
| 861132 | 24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet | SCD | f075a897-7bef-4799-b7e2-7e051c461443 | 11 |
| 861132 | alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral Tablet | SY | f075a897-7bef-4799-b7e2-7e051c461443 | 11 |
| 861132 | alfuzosin HCl 10 MG 24HR Extended Release Oral Tablet | PSN | 790fe381-4a83-402e-b6c0-2ecde9cac7a7 | 2 |
| 861132 | 24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet | SCD | 790fe381-4a83-402e-b6c0-2ecde9cac7a7 | 2 |
| 861132 | alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral Tablet | SY | 790fe381-4a83-402e-b6c0-2ecde9cac7a7 | 2 |
| 861132 | alfuzosin HCl 10 MG 24HR Extended Release Oral Tablet | PSN | 8a677905-e66d-44f7-b564-6c561387ed03 | 1 |
| 861132 | 24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet | SCD | 8a677905-e66d-44f7-b564-6c561387ed03 | 1 |
| 861132 | alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral Tablet | SY | 8a677905-e66d-44f7-b564-6c561387ed03 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 76282-302-01 | 76282030201 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-01) | 2012-10-02 | 0000-00-00 | No | No | Current |
| 76282-302-05 | 76282030205 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-05) | 2012-10-02 | 0000-00-00 | No | No | Current |
| 76282-302-10 | 76282030210 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-10) | 2012-10-02 | No | No | Current | |
| 76282-302-12 | 76282030212 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-12) | 2022-12-01 | 0000-00-00 | No | No | Current |
| 76282-302-90 | 76282030290 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-302-90) | 2019-01-01 | 0000-00-00 | No | No | Current |